STX2 and hemolytic-uremic syndrome: In this work we designed a high throughput screen (HTS) to identify compounds that preferentially affect expression of stx2. We focused on Stx2 because studies in primates have shown that administration of Stx2 alone can produce the symptoms of HUS, while administration of Stx1 at the same dose does not.